Share Price and Basic Stock Data
Last Updated: February 10, 2026, 9:55 pm
| PEG Ratio | -4.87 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Arex Industries Ltd operates in the textiles processing and texturising sector, currently priced at ₹141 with a market capitalization of ₹50.6 Cr. The company reported a trailing twelve months (TTM) revenue of ₹50.12 Cr, showing a consistent revenue pattern with a slight decline from ₹53.75 Cr in FY 2022 to ₹45.02 Cr in FY 2023. However, the quarterly sales figures have shown resilience, with the latest quarter (Sep 2023) recording sales of ₹12.80 Cr, up from ₹11.68 Cr in Jun 2023. This upward trend continued into Dec 2023, where sales reached ₹13.05 Cr. The operational performance is highlighted by the operating profit margin (OPM), which stood at 11.70%, signaling a stable operating environment, albeit lower than some industry peers, which typically range around 15%-20%. The company’s focus on enhancing its product portfolio appears to be a strategic move to capture greater market share within a competitive landscape.
Profitability and Efficiency Metrics
Arex Industries reported a net profit of ₹2.49 Cr, translating to an earnings per share (EPS) of ₹7.32 for the fiscal year ending March 2025. The company’s profitability has fluctuated, experiencing a decline in FY 2023 with a net profit of ₹0.70 Cr compared to ₹3.70 Cr in FY 2022. The interest coverage ratio (ICR) stood at a robust 8.13x, indicating strong earnings relative to interest expenses and reflecting effective debt management. However, the return on equity (ROE) at 9.08% and return on capital employed (ROCE) at 11.8% are below industry benchmarks, which often exceed 12% and 15%, respectively. Efficiency is further illustrated by the cash conversion cycle of 138.57 days, which, while improved, remains higher than the typical sector range of 90-120 days, suggesting potential improvements in inventory and receivables management.
Balance Sheet Strength and Financial Ratios
As of the latest reporting period, Arex Industries maintains total assets of ₹46.63 Cr against total liabilities of ₹46.63 Cr, indicating a balanced and stable financial position. The company’s borrowings have decreased to ₹10.72 Cr, reflecting prudent financial management. The long-term debt-to-equity ratio stands at 0.20, showcasing a low reliance on debt financing compared to the industry norm, typically around 0.5-1.0. Furthermore, the current ratio of 1.32 suggests sufficient liquidity to meet short-term obligations. The book value per share, which is ₹71.34, also indicates a solid asset base relative to its market price, thus providing a safety cushion for investors. However, the price-to-book value ratio of 2.12x suggests that the stock may be trading at a premium compared to its intrinsic value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Arex Industries shows strong promoter confidence, with promoters holding 70.60% of the equity as of Sep 2025. This significant stake demonstrates an alignment of interests between the management and shareholders, fostering an environment of stability. The number of shareholders has declined to 2,380, indicating potential consolidation of ownership. The public holding stood at 29.38%, which is relatively low, suggesting a concentrated ownership structure that may limit liquidity but also reflects a commitment from the promoters. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may raise concerns about broader market confidence, as institutional participation often enhances stock stability and credibility. This concentrated ownership could be a double-edged sword, providing stability while also raising risks related to market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Arex Industries faces both opportunities and challenges. On the one hand, the company’s strategic focus on expanding its product range and improving operational efficiency could enhance its competitive positioning in the textiles sector. However, external risks such as fluctuations in raw material prices and economic downturns could adversely impact profitability. Additionally, the company’s high cash conversion cycle indicates that improving working capital management could be critical for enhancing liquidity and operational efficiency. The current market dynamics suggest that Arex Industries could benefit from a strategic pivot towards more innovative product offerings and cost control measures. If the company successfully navigates these challenges, it may see improved profitability and investor confidence in the long run. Conversely, failure to address operational inefficiencies and market volatility could hinder growth prospects.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minaxi Textiles Ltd | 7.66 Cr. | 1.55 | 2.51/1.20 | 3.61 | 0.82 | 0.00 % | 2.20 % | 42.3 % | 1.00 |
| Gujarat Cotex Ltd | 13.2 Cr. | 9.26 | 15.9/6.72 | 22.4 | 5.36 | 0.00 % | 3.59 % | 3.26 % | 5.00 |
| Gini Silk Mills Ltd | 33.3 Cr. | 59.5 | 130/55.1 | 19.7 | 91.2 | 0.00 % | 3.23 % | 2.24 % | 10.0 |
| Dhanlaxmi Fabrics Ltd | 49.7 Cr. | 58.0 | 69.5/50.6 | 53.1 | 0.00 % | 8.07 % | 8.90 % | 10.0 | |
| Bluechip Tex Industries Ltd | 26.0 Cr. | 132 | 180/120 | 130 | 0.00 % | 4.77 % | 5.30 % | 10.0 | |
| Industry Average | 1,224.71 Cr | 122.34 | 40.61 | 81.67 | 0.35% | 11.05% | 12.54% | 7.18 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.19 | 10.87 | 11.68 | 12.80 | 13.05 | 13.48 | 12.97 | 12.34 | 13.20 | 12.64 | 11.27 | 13.01 | 12.99 |
| Expenses | 9.26 | 9.40 | 9.82 | 10.40 | 9.53 | 12.16 | 10.48 | 10.97 | 10.62 | 10.88 | 9.57 | 10.38 | 11.47 |
| Operating Profit | 1.93 | 1.47 | 1.86 | 2.40 | 3.52 | 1.32 | 2.49 | 1.37 | 2.58 | 1.76 | 1.70 | 2.63 | 1.52 |
| OPM % | 17.25% | 13.52% | 15.92% | 18.75% | 26.97% | 9.79% | 19.20% | 11.10% | 19.55% | 13.92% | 15.08% | 20.22% | 11.70% |
| Other Income | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest | 0.45 | 0.36 | 0.40 | 0.36 | 0.32 | 0.25 | 0.26 | 0.16 | 0.35 | 0.32 | 0.29 | 0.29 | 0.26 |
| Depreciation | 1.08 | 1.00 | 1.07 | 1.10 | 1.08 | 0.91 | 1.00 | 1.00 | 1.00 | 1.13 | 1.06 | 1.06 | 1.06 |
| Profit before tax | 0.42 | 0.18 | 0.39 | 0.94 | 2.12 | 0.25 | 1.23 | 0.86 | 1.23 | 0.35 | 0.35 | 1.28 | 0.20 |
| Tax % | 28.57% | 0.00% | 28.21% | 18.09% | 30.66% | 88.00% | 32.52% | 33.72% | 20.33% | 25.71% | 25.71% | 21.09% | -35.00% |
| Net Profit | 0.29 | 0.17 | 0.28 | 0.77 | 1.47 | 0.03 | 0.83 | 0.57 | 0.98 | 0.26 | 0.25 | 1.00 | 0.26 |
| EPS in Rs | 0.73 | 0.43 | 0.71 | 1.95 | 3.71 | 0.08 | 2.10 | 1.58 | 2.72 | 0.72 | 0.69 | 2.78 | 0.72 |
Last Updated: February 3, 2026, 4:16 am
Below is a detailed analysis of the quarterly data for Arex Industries Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 12.99 Cr.. The value appears to be declining and may need further review. It has decreased from 13.01 Cr. (Sep 2025) to 12.99 Cr., marking a decrease of 0.02 Cr..
- For Expenses, as of Dec 2025, the value is 11.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.38 Cr. (Sep 2025) to 11.47 Cr., marking an increase of 1.09 Cr..
- For Operating Profit, as of Dec 2025, the value is 1.52 Cr.. The value appears to be declining and may need further review. It has decreased from 2.63 Cr. (Sep 2025) to 1.52 Cr., marking a decrease of 1.11 Cr..
- For OPM %, as of Dec 2025, the value is 11.70%. The value appears to be declining and may need further review. It has decreased from 20.22% (Sep 2025) to 11.70%, marking a decrease of 8.52%.
- For Other Income, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Interest, as of Dec 2025, the value is 0.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.29 Cr. (Sep 2025) to 0.26 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Dec 2025, the value is 1.06 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.06 Cr..
- For Profit before tax, as of Dec 2025, the value is 0.20 Cr.. The value appears to be declining and may need further review. It has decreased from 1.28 Cr. (Sep 2025) to 0.20 Cr., marking a decrease of 1.08 Cr..
- For Tax %, as of Dec 2025, the value is -35.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.09% (Sep 2025) to -35.00%, marking a decrease of 56.09%.
- For Net Profit, as of Dec 2025, the value is 0.26 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Sep 2025) to 0.26 Cr., marking a decrease of 0.74 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.72. The value appears to be declining and may need further review. It has decreased from 2.78 (Sep 2025) to 0.72, marking a decrease of 2.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:12 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.70 | 33.04 | 32.15 | 34.94 | 37.66 | 40.72 | 47.17 | 40.88 | 53.75 | 45.02 | 51.01 | 51.14 | 50.12 |
| Expenses | 23.16 | 25.22 | 24.44 | 26.45 | 29.62 | 31.10 | 37.89 | 34.02 | 42.53 | 38.20 | 41.93 | 42.99 | 41.45 |
| Operating Profit | 8.54 | 7.82 | 7.71 | 8.49 | 8.04 | 9.62 | 9.28 | 6.86 | 11.22 | 6.82 | 9.08 | 8.15 | 8.67 |
| OPM % | 26.94% | 23.67% | 23.98% | 24.30% | 21.35% | 23.62% | 19.67% | 16.78% | 20.87% | 15.15% | 17.80% | 15.94% | 17.30% |
| Other Income | -0.13 | 0.08 | 0.06 | -0.06 | 0.11 | 0.42 | 0.15 | 0.08 | 0.04 | 0.23 | 0.10 | 0.74 | 0.04 |
| Interest | 1.07 | 0.77 | 0.72 | 1.02 | 1.09 | 2.54 | 3.13 | 2.98 | 2.11 | 1.81 | 1.33 | 1.09 | 1.25 |
| Depreciation | 4.05 | 3.13 | 2.54 | 2.51 | 2.54 | 4.02 | 4.85 | 4.76 | 4.49 | 4.23 | 4.16 | 4.13 | 4.25 |
| Profit before tax | 3.29 | 4.00 | 4.51 | 4.90 | 4.52 | 3.48 | 1.45 | -0.80 | 4.66 | 1.01 | 3.69 | 3.67 | 3.21 |
| Tax % | 33.13% | 32.50% | 36.36% | 34.29% | 23.67% | 27.59% | 38.62% | 25.00% | 20.60% | 30.69% | 31.17% | 28.07% | |
| Net Profit | 2.20 | 2.69 | 2.87 | 3.22 | 3.45 | 2.52 | 0.88 | -1.00 | 3.70 | 0.70 | 2.54 | 2.63 | 2.49 |
| EPS in Rs | 5.56 | 6.80 | 7.25 | 8.13 | 8.71 | 6.37 | 2.22 | -2.53 | 9.35 | 1.77 | 6.42 | 7.31 | 6.91 |
| Dividend Payout % | 16.20% | 13.25% | 41.39% | 24.60% | 22.96% | 31.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.27% | 6.69% | 12.20% | 7.14% | -26.96% | -65.08% | -213.64% | 470.00% | -81.08% | 262.86% | 3.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.58% | 5.50% | -5.05% | -34.10% | -38.12% | -148.56% | 683.64% | -551.08% | 343.94% | -259.31% |
Arex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -2% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | -11% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | -13% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: February 1, 2026, 4:19 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.60 | 3.60 |
| Reserves | 10.53 | 12.79 | 14.23 | 17.67 | 20.21 | 21.76 | 21.69 | 20.70 | 24.41 | 25.11 | 27.65 | 22.07 | 23.32 |
| Borrowings | 8.85 | 5.57 | 10.30 | 12.97 | 29.96 | 35.38 | 32.00 | 31.06 | 23.32 | 17.75 | 10.49 | 12.34 | 10.72 |
| Other Liabilities | 3.67 | 2.80 | 4.99 | 3.39 | 5.35 | 6.42 | 6.53 | 6.94 | 6.77 | 5.88 | 8.06 | 8.62 | 8.16 |
| Total Liabilities | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
| Fixed Assets | 15.07 | 13.68 | 17.68 | 20.15 | 17.78 | 46.36 | 43.21 | 39.41 | 36.14 | 33.39 | 30.36 | 26.99 | 24.85 |
| CWIP | 0.35 | -0.00 | 1.80 | -0.00 | 23.85 | -0.00 | -0.00 | -0.00 | 0.49 | -0.00 | 0.03 | 0.88 | 2.61 |
| Investments | 0.02 | 0.03 | 1.03 | 1.26 | 0.12 | 0.02 | -0.00 | 1.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other Assets | 11.57 | 11.41 | 12.97 | 16.58 | 17.73 | 21.14 | 20.97 | 22.24 | 21.83 | 19.31 | 19.77 | 18.76 | 18.34 |
| Total Assets | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
Below is a detailed analysis of the balance sheet data for Arex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.60 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.60 Cr..
- For Reserves, as of Sep 2025, the value is 23.32 Cr.. The value appears strong and on an upward trend. It has increased from 22.07 Cr. (Mar 2025) to 23.32 Cr., marking an increase of 1.25 Cr..
- For Borrowings, as of Sep 2025, the value is 10.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 12.34 Cr. (Mar 2025) to 10.72 Cr., marking a decrease of 1.62 Cr..
- For Other Liabilities, as of Sep 2025, the value is 8.16 Cr.. The value appears to be improving (decreasing). It has decreased from 8.62 Cr. (Mar 2025) to 8.16 Cr., marking a decrease of 0.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 45.80 Cr.. The value appears to be improving (decreasing). It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
- For Fixed Assets, as of Sep 2025, the value is 24.85 Cr.. The value appears to be declining and may need further review. It has decreased from 26.99 Cr. (Mar 2025) to 24.85 Cr., marking a decrease of 2.14 Cr..
- For CWIP, as of Sep 2025, the value is 2.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.88 Cr. (Mar 2025) to 2.61 Cr., marking an increase of 1.73 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18.34 Cr.. The value appears to be declining and may need further review. It has decreased from 18.76 Cr. (Mar 2025) to 18.34 Cr., marking a decrease of 0.42 Cr..
- For Total Assets, as of Sep 2025, the value is 45.80 Cr.. The value appears to be declining and may need further review. It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
Notably, the Reserves (23.32 Cr.) exceed the Borrowings (10.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.31 | 2.25 | -2.59 | -4.48 | -21.92 | -25.76 | -22.72 | -24.20 | -12.10 | -10.93 | -1.41 | -4.19 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68.62 | 62.53 | 80.27 | 82.21 | 79.96 | 94.12 | 82.64 | 103.21 | 64.10 | 66.00 | 68.41 | 57.60 |
| Inventory Days | 110.40 | 107.11 | 137.21 | 139.33 | 126.72 | 201.12 | 198.88 | 224.84 | 228.87 | 234.62 | 191.74 | 194.58 |
| Days Payable | 6.63 | 3.77 | 19.66 | 17.54 | 31.68 | 81.26 | 100.09 | 107.42 | 92.02 | 82.61 | 94.31 | 113.61 |
| Cash Conversion Cycle | 172.39 | 165.87 | 197.82 | 204.00 | 175.00 | 213.98 | 181.42 | 220.64 | 200.95 | 218.01 | 165.84 | 138.57 |
| Working Capital Days | 42.14 | 43.53 | 32.36 | 53.90 | 64.55 | 68.48 | 65.00 | 82.32 | 51.95 | 74.99 | 63.83 | 29.55 |
| ROCE % | 20.35% | 20.81% | 20.55% | 19.21% | 12.62% | 9.86% | 7.65% | 3.78% | 12.64% | 5.52% | 11.27% | 11.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Diluted EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Cash EPS (Rs.) | 18.80 | 16.93 | 12.47 | 20.69 | 9.49 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Revenue From Operations / Share (Rs.) | 142.11 | 128.86 | 113.73 | 135.78 | 103.26 |
| PBDIT / Share (Rs.) | 24.71 | 23.19 | 17.83 | 28.42 | 17.53 |
| PBIT / Share (Rs.) | 13.23 | 12.68 | 7.13 | 17.07 | 5.50 |
| PBT / Share (Rs.) | 10.19 | 9.33 | 2.55 | 11.75 | -2.04 |
| Net Profit / Share (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| PBDIT Margin (%) | 17.38 | 17.99 | 15.67 | 20.93 | 16.97 |
| PBIT Margin (%) | 9.30 | 9.84 | 6.27 | 12.57 | 5.32 |
| PBT Margin (%) | 7.16 | 7.23 | 2.24 | 8.65 | -1.97 |
| Net Profit Margin (%) | 5.15 | 4.98 | 1.55 | 6.87 | -2.45 |
| Return on Networth / Equity (%) | 10.26 | 8.04 | 2.41 | 13.03 | -4.07 |
| Return on Capital Employeed (%) | 14.40 | 12.41 | 6.68 | 14.64 | 4.24 |
| Return On Assets (%) | 5.64 | 5.07 | 1.32 | 6.32 | -1.60 |
| Long Term Debt / Equity (X) | 0.20 | 0.20 | 0.39 | 0.56 | 1.02 |
| Total Debt / Equity (X) | 0.48 | 0.33 | 0.61 | 0.82 | 1.07 |
| Asset Turnover Ratio (%) | 1.06 | 0.99 | 0.81 | 0.88 | 0.64 |
| Current Ratio (X) | 1.32 | 1.94 | 1.73 | 1.65 | 1.84 |
| Quick Ratio (X) | 0.74 | 1.12 | 0.88 | 0.86 | 1.12 |
| Inventory Turnover Ratio (X) | 6.47 | 1.73 | 1.46 | 1.74 | 1.72 |
| Interest Coverage Ratio (X) | 8.13 | 6.91 | 3.89 | 5.34 | 2.33 |
| Interest Coverage Ratio (Post Tax) (X) | 3.41 | 2.92 | 1.39 | 2.76 | 0.66 |
| Enterprise Value (Cr.) | 66.54 | 65.94 | 49.05 | 83.11 | 53.76 |
| EV / Net Operating Revenue (X) | 1.30 | 1.29 | 1.09 | 1.55 | 1.32 |
| EV / EBITDA (X) | 7.48 | 7.18 | 6.95 | 7.39 | 7.75 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| Price / BV (X) | 2.12 | 1.76 | 1.09 | 2.12 | 1.12 |
| Price / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| EarningsYield | 0.04 | 0.04 | 0.02 | 0.06 | -0.03 |
After reviewing the key financial ratios for Arex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 18.80. This value is within the healthy range. It has increased from 16.93 (Mar 24) to 18.80, marking an increase of 1.87.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.11. It has increased from 128.86 (Mar 24) to 142.11, marking an increase of 13.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 23.19 (Mar 24) to 24.71, marking an increase of 1.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.68 (Mar 24) to 13.23, marking an increase of 0.55.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.19. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 10.19, marking an increase of 0.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For PBDIT Margin (%), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.38, marking a decrease of 0.61.
- For PBIT Margin (%), as of Mar 25, the value is 9.30. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 9.30, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 7.23 (Mar 24) to 7.16, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 5.15. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.15, marking an increase of 0.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.26. This value is below the healthy minimum of 15. It has increased from 8.04 (Mar 24) to 10.26, marking an increase of 2.22.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.40. This value is within the healthy range. It has increased from 12.41 (Mar 24) to 14.40, marking an increase of 1.99.
- For Return On Assets (%), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 5.64, marking an increase of 0.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.20.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.33 (Mar 24) to 0.48, marking an increase of 0.15.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has increased from 0.99 (Mar 24) to 1.06, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.94 (Mar 24) to 1.32, marking a decrease of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.74, marking a decrease of 0.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.47. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 6.47, marking an increase of 4.74.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.13. This value is within the healthy range. It has increased from 6.91 (Mar 24) to 8.13, marking an increase of 1.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.41. This value is within the healthy range. It has increased from 2.92 (Mar 24) to 3.41, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.54. It has increased from 65.94 (Mar 24) to 66.54, marking an increase of 0.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 1.30, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.48, marking an increase of 0.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.76 (Mar 24) to 2.12, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Arex Industries Ltd:
- Net Profit Margin: 5.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.4% (Industry Average ROCE: 11.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.26% (Industry Average ROE: 12.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.6 (Industry average Stock P/E: 40.61)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Processing/Texturising | 612, GIDC Industrial Estate, Chhatral, Gandhi Nagar Dist. Gujarat 382729 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh A Bilgi | Managing Director & CFO |
| Mr. Neel D Bilgi | Managing Director |
| Mr. Chirag D Bilgi | Managing Director |
| Mr. Pragnesh K Shah | Director |
| Mr. Manoj U Shah | Director |
| Mrs. Rekha Agarwal | Independent Director |
| Mr. Aviv J Divekar | Independent Director |
| Mr. Laxman C Tilani | Director |
| Mr. Sunil Bansibhai Shah | Independent Director |
FAQ
What is the intrinsic value of Arex Industries Ltd?
Arex Industries Ltd's intrinsic value (as of 14 February 2026) is ₹149.21 which is 5.82% higher the current market price of ₹141.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹50.6 Cr. market cap, FY2025-2026 high/low of ₹175/128, reserves of ₹23.32 Cr, and liabilities of ₹45.80 Cr.
What is the Market Cap of Arex Industries Ltd?
The Market Cap of Arex Industries Ltd is 50.6 Cr..
What is the current Stock Price of Arex Industries Ltd as on 14 February 2026?
The current stock price of Arex Industries Ltd as on 14 February 2026 is ₹141.
What is the High / Low of Arex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Arex Industries Ltd stocks is ₹175/128.
What is the Stock P/E of Arex Industries Ltd?
The Stock P/E of Arex Industries Ltd is 28.6.
What is the Book Value of Arex Industries Ltd?
The Book Value of Arex Industries Ltd is 74.8.
What is the Dividend Yield of Arex Industries Ltd?
The Dividend Yield of Arex Industries Ltd is 0.00 %.
What is the ROCE of Arex Industries Ltd?
The ROCE of Arex Industries Ltd is 11.8 %.
What is the ROE of Arex Industries Ltd?
The ROE of Arex Industries Ltd is 9.08 %.
What is the Face Value of Arex Industries Ltd?
The Face Value of Arex Industries Ltd is 10.0.